PTGER4 and hydrops fetalis: Especially receptor 4 of PGE2, E-series prostanoid receptor 4 (EP4), is currently emerging as most versatile and promising among PGE2 receptors, and the PGE2/EP4 signalling is thought to be the potential targets to HF and myocardial ischemia [35].